Trials / Unknown
UnknownNCT03755830
Prostaglandin F2-alpha (PGF2α) in Vitiligo
Study of the Cutaneous Expression of Prostaglandin F2-alpha (PGF2α) in Vitiligo Patients: a Case-control Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
study the cutaneous expression of PGF2α in vitiligo patients and compare it with normal control subjects.
Detailed description
Measurement of tissue levels of PGF2α in vitiligo patients and compare them with healthy controls.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Skin biopsy | Two skin biopsies (lesional and non-lesional) will be taken from every patient. Also a skin biopsy will be taken from each control subject. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-07-01
- Completion
- 2019-07-01
- First posted
- 2018-11-28
- Last updated
- 2018-11-28
Source: ClinicalTrials.gov record NCT03755830. Inclusion in this directory is not an endorsement.